Family Medicine · Alhambra, CA
NPI
1306919899
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2140 W Valley Blvd
Alhambra, CA, 91803
Phone (626) 284-8881
Groups this clinician bills Medicare through
Medicare paid, 2024
$372K
5,797 services
Medicare patients, 2024
375
Average age 77
Drug cost, 2024
$1.6M
15,921 prescriptions
Company payments, 2025
$474
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew K Mo was code 99442 (telephone services), 1,959 times for 336 patients. In total Matthew K Mo billed 5,797 services in 24 codes, and Medicare paid $372K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99442 Telephone Services | Office | 1,959 | 336 | $69.55 | $136K |
| 99213 Office E&M - Established | Office | 1,469 | 327 | $57.04 | $84K |
| 99441 Telephone Services | Office | 780 | 264 | $46.06 | $36K |
| 99212 Office E&M - Established | Office | 327 | 168 | $40.51 | $13K |
| 99233 Hospital E&M - Subsequent | Facility | 273 | 23 | $92.32 | $25K |
| 99443 Telephone Services | Office | 183 | 131 | $73.00 | $13K |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 165 | 165 | $169.06 | $28K |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 141 | 92 | $34.23 | $4,827 |
| G0008 Administration of influenza virus vaccine | Office | 70 | 67 | $35.02 | $2,451 |
| 90656 Vaccine Product | Office | 60 | 60 | $21.90 | $1,314 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 55 | 55 | $133.10 | $7,320 |
| 99308 SNF E&M | Facility | 52 | 12 | $59.57 | $3,098 |
| 64450 Musculoskeletal | Office | 45 | 23 | $61.91 | $2,786 |
| 99214 Office E&M - Established | Office | 44 | 42 | $73.80 | $3,247 |
| 96372 Injection Administration | Office | 40 | 13 | $11.35 | $454 |
By year: 2022 $373K for 5,668 services; 2023 $374K for 6,034 services; 2024 $372K for 5,797 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew K Mo prescribed most often to Medicare patients was Atorvastatin Calcium, with 944 prescriptions and refills. In total Matthew K Mo wrote 15,921 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 944 | 1,685 | 206 | $4,977 |
| Amlodipine Besylate Generic | 849 | 1,464 | 166 | $2,147 |
| Montelukast Sodium Generic | 608 | 728 | 181 | $2,420 |
| Losartan Potassium Generic | 483 | 870 | 85 | $2,762 |
| Famotidine Generic | 416 | 579 | 106 | $2,149 |
| Celecoxib Generic | 414 | 579 | 109 | $6,680 |
| Irbesartan Generic | 401 | 670 | 85 | $4,128 |
| Vascepa Icosapent Ethyl | 376 | 498 | 64 | $132K |
| Levocetirizine Dihydrochloride Generic | 343 | 464 | 88 | $1,827 |
| Metformin Hcl Generic | 299 | 552 | 61 | $1,196 |
| Donepezil Hcl Generic | 289 | 365 | 48 | $1,079 |
| Azithromycin Generic | 275 | 275 | 164 | $735 |
| Triamcinolone Acetonide Generic | 272 | 282 | 84 | $2,227 |
| Zolpidem Tartrate Generic | 247 | 269 | 65 | $565 |
| Januvia Sitagliptin Phosphate | 235 | 395 | 50 | $199K |
Brand drugs: 2,380 claims; generic drugs: 13,483 claims; opioid claims: 138.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew K Mo $474 ($474 in general payments such as food, travel and fees) from 5 companies. The largest payer was GlaxoSmithKline, LLC. with $201.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.